Expression of hyaluronan in benign and malignant breast lesions

被引:0
|
作者
Auvinen, PK
Parkkinen, JJ
Johansson, RT
Agren, UM
Tammi, RH
Eskelinen, MJ
Kosma, VM
机构
[1] KUOPIO UNIV HOSP, DEPT PATHOL, SF-70210 KUOPIO, FINLAND
[2] UNIV KUOPIO, DEPT PATHOL & FORENS MED, FIN-70211 KUOPIO, FINLAND
[3] UNIV KUOPIO, DEPT ANAT, FIN-70211 KUOPIO, FINLAND
[4] KUOPIO UNIV HOSP, DEPT SURG, SF-70210 KUOPIO, FINLAND
关键词
D O I
10.1002/(SICI)1097-0215(19971021)74:5<477::AID-IJC1>3.0.CO;2-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hyaluronan (HA) is one of the extracellular-matrix components involved in wound healing, tumour growth and metastasis, Due to the limited data on HA expression in benign and malignant breast lesions, we analyzed its presence in these lesions by using the biotinylated-hyaluronan-binding region and the link-protein complex (bHABC) of cartilage proteoglycan as a specific probe. In all benign breast lesions, the expression of HA was restricted to the stromal connective tissue, the ductal epithelial cells being completely devoid of HA. In malignant breast tumours, the intensity of stromal HA staining was significantly stronger than in benign lesions. In addition, HA was detected on cell membranes or in cytoplasms of adenocarcinoma cells, in some cases of ductal carcinoma in situ and in 31% of malignant tumours, The staining pattern was mostly similar in all breast-cancer types studied, i.e., ductal, lobular, tubular, mucinous and medullary, In ductal breast cancer, intense HA expression in stroma and carcinoma cells correlated statistically significantly to poor differentation of carcinoma, suggesting that altered HA expression may affect the mechanisms of breast-cancer progression. (C) 1997 Wiley-Liss, Inc.
引用
收藏
页码:477 / 481
页数:5
相关论文
共 50 条
  • [41] SIS PDGF-B EXPRESSION IN BENIGN AND MALIGNANT HUMAN-BREAST LESIONS
    RO, J
    BRESSER, J
    RO, JY
    BRASFIELD, F
    HORTOBAGYI, G
    BLICK, M
    ONCOGENE, 1989, 4 (03) : 351 - 354
  • [43] C-KIT expression in columnar cell lesions of the breast accompanied by benign and malignant breast diseases
    Polat, Ayse
    PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (11) : 765 - 769
  • [44] Genetic alterations in benign, preneoplastic and malignant breast lesions
    Karaman, Ali
    Kabalar, Mehmet Esref
    Aylu, Belkis
    Binici, Dogan Nasir
    Coskun, Muharrem
    Tos, Tulay
    Albayrak, Yavuz
    CURRENT OPINION IN BIOTECHNOLOGY, 2011, 22 : S102 - S103
  • [45] Genetic alterations in benign, preneoplastic and malignant breast lesions
    Kabalar, Mehmet Esref
    Karaman, Ali
    Aylu, Belkis
    Ozmen, Sevilay Akalp
    Erdem, Ilknur
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (03) : 319 - 325
  • [46] Optical discrimination between malignant and benign breast lesions?
    Quarto, Giovanna
    Pifferi, Antonio
    Cubeddu, Rinaldo
    Ieva, Francesca
    Paganoni, Anna Maria
    Abbate, Francesca
    Cassano, Enrico
    Taroni, Paola
    DIFFUSE OPTICAL IMAGING V, 2015, 9538
  • [47] Differentiation of benign and malignant breast lesions by mechanical imaging
    Vladimir Egorov
    Thomas Kearney
    Stanley B. Pollak
    Chand Rohatgi
    Noune Sarvazyan
    Suren Airapetian
    Stephanie Browning
    Armen Sarvazyan
    Breast Cancer Research and Treatment, 2009, 118 : 67 - 80
  • [48] Quantitative elastography in differentiating benign and malignant breast lesions
    Pekoz, Burcak Cakir
    Purbager, Aysin
    Aslan, Hulya
    Agildere, Ahmet Muhtesem
    CUKUROVA MEDICAL JOURNAL, 2016, 41 (04): : 628 - 638
  • [49] Automated Classification of Benign and Malignant Proliferative Breast Lesions
    Radiya-Dixit, Evani
    Zhu, David
    Beck, Andrew H.
    SCIENTIFIC REPORTS, 2017, 7
  • [50] TESTOSTERONE-METABOLISM IN BENIGN AND MALIGNANT BREAST LESIONS
    ROSE, LI
    UNDERWOOD, RH
    DUNNING, MT
    WILLIAMS, GH
    PINKUS, GS
    CANCER, 1975, 36 (02) : 399 - 403